학술논문
351 (PB-146) - NorBreast-231 trial: a randomized phase II study evaluating weekly oral vinorelbine versus weekly paclitaxel in estrogen receptor positive, HER2-negative patients with advanced breast cancer
Document Type
Abstract
Author
Source
In European Journal of Cancer April 2018 92 Supplement 3:S98-S98
Subject
Language
ISSN
0959-8049